Results 81 to 90 of about 21,713 (188)

What to Do with Epicardial Coronary Artery Abnormalities That do not Result in Myocardial Ischemia?

open access: yesCardiovascular Innovations and Applications, 2019
When epicardial arteries with minimal CAD do not limit flow are found at coronary angiography, all cardiologists agree that aggressive risk factor modification and use of appropriate drugs are warranted.
C. Richard Conti
doaj   +1 more source

AP‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Numerous cellular functions, such as apoptosis, proliferation, differentiation, survival, transformation and cell migration, are regulated by a crucial transcription factor called activator protein 1 (AP‐1). Growing evidence indicates that AP‐1 is involved in severe conditions like fibrosis, cancer, and organ damage, as well as inflammatory ...
Maryam Mahjoubin‐Tehran   +5 more
wiley   +1 more source

The strategy of surgical revascularization of coronary arteries in a multi-vessel lesion

open access: yesКлиническая практика, 2019
This review presents the basic approaches for the surgical myocardial revascularization in patients with multivessel coronary lesions. The methods of coronary artery bypass grafting, balloon angioplasty, stenting using holometallic stents and drug-coated
Aleksandr V. Bocharov, Leonid V. Popov
doaj   +1 more source

Coronary Artery Aneurysm Post Drug-Coated Balloon Angioplasty

open access: yesJACC: Case Reports
Drug-coated balloons have emerged as effective therapy for treating in-stent restenosis and de novo lesions. The animal studies have shown the mechanism of action of paclitaxel-coated balloon in coronary arteries which leads to medial necrosis that may ...
Aninka Saboe, MD   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy